Esthesioneuroblastoma: Is there a role for elective neck treatment?
β Scribed by Dr. Jonathan J. Beitler; Dr. Daniel E. Fass; Dr. Harry A. Brenner; Dr. Andrew Huvos; Dr. Louis B. Harrison; Dr. Steven A. Leibel; Dr. Zvi Fuks
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 483 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
A retrospective review of the Memorial Sloan Kettering Cancer Center experience (MSKCC) with esthesioneuroblastoma was performed. From 1975 to 1985 14 cases were identified. Overall 5-and 10-year survival was 86% and 70%, respectively. Four local failures were observed and 4 neck failures were observed. A review of the literature since 1966 revealed an unexpectedly high incidence of neck failure, and of the 21 of 11 0 patients with neck failures that were identified through the literature, there were 6 subsequent deaths. HEAD 81 NECK 1991;13:321-326
Esthesioneuroblastoma is an uncommon disease with a long natural history. Five-year survival after recurrence is common. In addition to defining a staging system (group A: tumor confined to the nasal cavity; group B: tumor involving nasal cavity and paranasal sinuses; group C: tumor beyond the nasal cavity and paranasal sinuses),
From the Departments of Radiation Oncology (all doctors but one) and Pathology (Dr. Huvos), Memorial Sloan-
π SIMILAR VOLUMES
## Purpose: To determine the extent of the required neck dissection for patients with persistent lymphadenopathy after definitive radiation therapy for oropharyngeal cancer. if feasible, a conservative approach using selective neck dissection would likely minimize the extent of neck fibrosis and ot
This study examines patterns of early metastatic spread as recorded in 19 clinically negative, histologically positive (occult) neck dissection specimens. Microscopic metastatic deposits were detected in this study in nodes measuring 10 mm and less. No nodes with extension of tumor beyond the capsul